User profiles for Thomas F. Hany
 | Thomas F. HanyUniversität Zürich Verified email at mri-roentgen.ch Cited by 14760 |
[HTML][HTML] Staging of non–small-cell lung cancer with integrated positron-emission tomography and computed tomography
D Lardinois, W Weder, TF Hany… - … England Journal of …, 2003 - Mass Medical Soc
Background We compared the diagnostic accuracy of integrated positron-emission tomography
(PET) and computed tomography (CT) with that of CT alone, that of PET alone, and that …
(PET) and computed tomography (CT) with that of CT alone, that of PET alone, and that …
Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer
…, OT Giger, A Gelet, T Cservenyàk, TF Hany - European journal of …, 2008 - Springer
… The aim of our study was to further evaluate the accuracy of [ 18 F]choline for the initial …
diagnosis of PC consists of a bone scan or [ 18 F]-fluoride PET/CT to rule out bone metastases …
diagnosis of PC consists of a bone scan or [ 18 F]-fluoride PET/CT to rule out bone metastases …
Integrated PET/CT: Current Applications and Future Directions1
GK von Schulthess, HC Steinert, TF Hany - Radiology, 2006 - pubs.rsna.org
For the past 5 years, combined positron emission tomography (PET) and computed tomography
(CT), or PET/CT, has grown because the PET portion provides information that is very …
(CT), or PET/CT, has grown because the PET portion provides information that is very …
Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region
TF Hany, E Gharehpapagh, EM Kamel, A Buck… - European journal of …, 2002 - Springer
Increased symmetrical fluorine-18 fluorodeoxyglucose (FDG) uptake in the cervical and
thoracic spine region is well known and has been attributed to muscular uptake. The purpose of …
thoracic spine region is well known and has been attributed to muscular uptake. The purpose of …
Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging—do we need contrast-enhanced CT?
NG Schaefer, TF Hany, C Taverna, B Seifert… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To retrospectively compare diagnostic value of coregistered fluorine 18
fluorodeoxyglucose positron emission tomographic (PET) and computed tomographic (CT) scans …
fluorodeoxyglucose positron emission tomographic (PET) and computed tomographic (CT) scans …
PET diagnostic accuracy: improvement with in-line PET-CT system: initial results
TF Hany, HC Steinert, GW Goerres, A Buck… - Radiology, 2002 - pubs.rsna.org
The authors describe the initial application for tumor staging with an in-line system with a
positron emission tomographic (PET) scanner and a multi–detector row helical computed …
positron emission tomographic (PET) scanner and a multi–detector row helical computed …
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Objective: To compare the diagnostic value of contrast-enhanced CT (ceCT) and 2-[18-F]-fluoro-2-deoxyglucose-PET/CT
in patients with metastatic colorectal cancer to the liver. …
in patients with metastatic colorectal cancer to the liver. …
Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness
…, P Bauerfeind, BC Pestalozzi, TF Hany… - Annals of …, 2005 - journals.lww.com
Objective: We sought to determine the impact of positron emission tomography/computed
tomography (PET/CT) on the management of presumed resectable pancreatic cancer and to …
tomography (PET/CT) on the management of presumed resectable pancreatic cancer and to …
Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma
H Petrowsky, P Wildbrett, DB Husarik, TF Hany… - Journal of …, 2006 - Elsevier
BACKGROUND/AIMS: (1) To evaluate the diagnostic value of integrated positron emission
and computed tomography (PET/CT) in comparison with contrast-enhanced CT (ceCT) to …
and computed tomography (PET/CT) in comparison with contrast-enhanced CT (ceCT) to …
18F‐choline and/or 11C‐acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate‐specific antigen values …
OBJECTIVES To assess the value of positron emission tomography (PET)/computed tomography
(CT) with either 18 F‐choline and/or 11 C‐acetate, of residual or recurrent tumour after …
(CT) with either 18 F‐choline and/or 11 C‐acetate, of residual or recurrent tumour after …